On day 60, the serum IgM levels were significantly higher in the AMP, TB, and AMP&TB groups than those in the CON group (p < .01) but did not differ significantly among treatment groups on day 75 (p > .05) (Table 5). The gene discussed is CD40LG; the disease is tuberculosis.